Incannex Healthcare Inc (IXHL) Quarterly Institutional 13F Update (Q2 2026)

IXHL ranks #8931 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

IXHL is a disclosed holding of Israel Englander (Millennium Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

16 institutions disclose a position in IXHL, but none treat it as a major bet — even AdvisorShares Investments LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

IXHL is up 2.8% today, and institutions have been net buyers of $1.2M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

IXHL reported a net loss of $46.9M in its latest fiscal year.

• Not yet profitable — net loss of $46.9M in the latest fiscal year
• Revenue grew 616.7% year over year
• Net income declined year over year, from -$18.5M to -$46.9M
• Operating cash flow was negative, using $12.5M in cash
• Current ratio of 2.86x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.53x equity — within a conventional range